Free shipping on all orders over $ 500

APS-2-79 

Cat. No. M29098

All AbMole products are for research use only, cannot be used for human consumption.

APS-2-79  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

APS-2-79 is a KSR-dependent MEK antagonist. APS-2-79 inhibits ATPbiotin binding to KSR2 within the KSR2-MEK1 complexe with an IC50 of 120 nM. APS-2-79 makes the stabilization of the KSR inactive state antagonizes oncogenic Ras-MAPK signaling.

Chemical Information
Molecular Weight 387.43
Formula C23H21N3O3
CAS Number 2002381-25-9
Form Solid
Solubility (25°C) DMSO 20 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Beth K Neilsen, et al. Expert Opin Ther Targets. KSR as a therapeutic target for Ras-dependent cancers

[2] Neil S Dhawan, et al. Nature. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling

Related MEK Products
Balamapimod

Balamapimod (MKI 833) is a reversible Ras/Raf/MEK inhibitor with potential anti-tumor activity.

PD-334581 

PD-334581 is a MEK1 inhibitor.

Tunlametinib

Tunlametinib, an antineoplastic agent, is a MEK1/2 inhibitor.

Glycinexylidide

Glycinexylidide (GX) is the active metabolite of Lidocaine.

Xantocillin

Xantocillin (Xanthocillin X) is a marine agent extracted from Penicillium commune, induces autophagy through inhibition of the MEK/ERK pathway.

  Catalog
Abmole Inhibitor Catalog




Keywords: APS-2-79  supplier, MEK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.